March 2017 CPN

CPN

Community Pharmacy News – March 2017

Preparing for Quality Payments The latest guidance and resources on the Quality Payments Scheme, plus we answer your queries

Promoting community pharmacy | The Falsified Medicines Directive | Drug Tariff Watch

services and commissioning

The healThcare landscape

lpcs

Quality Payments guidance published by NHS England NHS England guidance document clarifies outstanding information regarding how the Quality Payments Scheme will operate.

NHS England has published further guidance on the Quality Payments Scheme, providing clarification on how community pharmacy contractors can meet the gateway criteria and the eight quality criteria.

The guidance document also details the process to follow to claim a Quality Payment, as well as the time periods in which a Quality Payment can be claimed.

PSNC strongly encourages all contractors to read the new NHS England guidance, as well as the gateway criteria guidance, to ensure they are fully briefed on the requirements of the Quality Payments Scheme.

Please note, contractors should make sure that they have the latest version of

the Pharmacy Quality Payments Quality Criteria Guidance from NHS England as a newer version was uploaded on 3rd March due to an error in the original.

The original version provided instructions on how to upload the Community Pharmacy Patient Questionnaire (CPPQ) results; however, these were slightly different to the instructions stated in the NHS Choices User Guide on uploading CPPQ results to a contractor’s NHS Choices profile.

The most up-to-date version of this new guidance, which should be read in conjunction with the gateway criteria guidance issued by NHS England on 23rd December 2016, can be found on NHS England’s website and is linked to from PSNC’s Quality Payments hub: psnc.org.uk/quality

Quality Payments Scheme webinar update from PSNC PSNC held a webinar update on the Quality Payments Scheme in mid-March. On the night Alastair Buxton, Director of NHS Services at PSNC, talked viewers through each of the criteria, explaining how to meet them and the self-declaration process.

Watching this 60-minute webinar will give you a comprehensive update on the Quality Payments Scheme with all the latest information available from NHS England. A recording of the PSNC webinar is now available to watch at: psnc.org.uk/webinar

New and updated Quality Payments resources Following the publication of NHS England’s Quality Criteria Guidance, PSNC has updated its resources based on the new guidance, as well as creating a new hub page to support community pharmacy contractors that wish to work towards achieving the Healthy Living Pharmacy (HLP) level 1 Quality Payment criterion.

Resource

Description

PSNC Briefing 013/17: Quality Payments – what pharmacy contractors need to do

This Briefing provides an overview of how the Quality Payments Scheme works.

Suggested plan for contractors

Firstly, PSNC’s ‘Health promotion ideas for pharmacy teams hub page’ provides links to different topics which pharmacy teams can use as a focus for their HLP Health Promotion Zone or they can be used in other health promotion work within and outside the pharmacy depending on the needs of the community.

Community pharmacy contractors and their teams will need to decide how to approach achieving the gateway and quality criteria in a way that works for them. There will be no ‘one size fits all approach’, but the suggested plan is one approach to prioritising activity to meet all the criteria, which contractors may want to consider adopting.

PSNC Briefing 014/17: Quality Payments – referrals for asthma reviews

This Briefing provides an overview of how to achieve the ‘referrals for asthma reviews’ quality criterion of the Quality Payment Scheme and details the PSNC resources available to assist with this.

PSNC Briefing 016/17: Quality Payments – How to become a Healthy Living Pharmacy Level 1

This Briefing provides an overview of how to achieve the Healthy Living Pharmacy (HLP) criterion of the Quality Payments Scheme and lists the PSNC resources available to assist with this.

HLP Level 1 Flow chart

A flow chart detailing the process to follow to achieve HLP Level 1.

And PSNC Briefing 011/17: Holding a health promotion event/campaign has been developed to provide guidance for contractors and their teams on holding an event/campaign as part of their HLP work. The template checklist and questionnaire that are included in the Briefing are also available as standalone documents at: psnc.org.uk/hlp Secondly, details of our newly updated resources are listed opposite - find these at: psnc.org.uk/quality 2 Community Pharmacy News – March 2017

HLP Level 1 Evidence portfolio A workbook that pharmacy teams can use to guide workbook them through the HLP quality criteria and assist them with recording their evidence to show they have reached HLP Level 1.

psnc’s work

funding and sTaTisTics

conTracT and iT

dispensing and supply

Answered: Your Quality Payment queries The team at PSNC has received a number of queries on the Quality Payments Scheme in the run up to the first review point. Below are some of the questions asked:

1

HLP quality criterion: My pharmacy achieved Healthy Living Pharmacy (HLP) status before the self-assessment process was announced. Does this mean my pharmacy meets the HLP Level 1 status?

It will depend on when the pharmacy achieved their HLP status: • Pharmacies that were accredited as an HLP locally between 1st December 2014 and 28th April 2017, and have a copy of the signed and dated documentation that demonstrates this, will not need to go through the profession-led self-assessment process set by Public Health England (PHE) to qualify for the quality criterion.

• Pharmacies that were accredited prior to 1st December 2014 as an HLP, and have a copy of the signed and dated documentation that demonstrates this, will need to complete the profession led self-assessment to show they are meeting the requirements of a HLP Level 1 as defined by PHE on the day of the review. The contractor will not need to register their pharmacy by completing the assessment of compliance on the Royal Society for Public Health website as this is just for pharmacies who are registering as an HLP for the first time.

2

HLP quality criterion: How often (if at all) will the leadership and Royal Society for Public Health clinical champion training need to be repeated?

There is no reference to the need for repeated training in the HLP quality requirements, so as long as a contractor has staff in post that have undertaken the relevant training, that will meet the requirements.

3

Asthma referrals quality criterion: What if I haven't been able to identify any asthma patients for whom more than 6 short acting bronchodilator inhalers were dispensed without any corticosteroid inhaler within a 6-month period?

Where no patients are identified for referral, the contractor will still be eligible for payment as long as they can evidence that they have been working to identify suitable patients and that they have a process in place for referral should they identify someone.

PSNC has produced a suggested process for referring patients for an asthma review which can be found in our Quality Payments hub: psnc.org.uk/asthmareferrals

4

Dementia Friends quality criterion: My pharmacy team have all become Dementia Friends but we haven’t received our badges yet. Will we still meet the quality criterion if they fail to arrive by the April review point?

Yes, if the pharmacy team has watched the online videos and submitted their details to Dementia Friends as stated in PSNC Briefing 073/16: Quality Payments – How to become a Dementia Friend (find it at: psnc.org.uk/briefings), the pharmacy will still meet the quality criterion. Dementia Friends badges are not required to meet the quality criterion.

The Alzheimer’s Society has seen an increase in the number of pharmacy teams becoming Dementia Friends since the introduction of the Quality Payments Scheme and therefore the number of requests for Dementia Friends badges has also increased. Due to this increase in demand, it may therefore be a number of weeks before your pharmacy team receive their Dementia Friends badges.

5

Do I need to submit evidence to the Pricing Authority to show that I have met the gateway and quality criteria when I submit my declaration?

No, evidence does not need to be submitted during the declaration process. However, contractors’ declarations of compliance with the gateway and quality criteria may be subject to spot checks by NHS England or the Pricing Authority as part of their usual monitoring process for the Community Pharmacy Contractual Framework (CPCF).

Still got questions? Check out our FAQ database at: psnc.org.uk/qualityFAQs psnc.org.uk 3

psnc’s work

funding and sTaTisTics

conTracT and iT

Promoting community pharmacy services Here we update you on PSNC’s national public affairs work, including engaging with politicians and creating resources to help LPCs engage with them too.

Whilst PSNC continues to work with the cross-pharmacy communications group to focus on continuing engagement with our key supportive MPs from across all parties, we have also been focusing on two other key areas: producing resources to promote the Community Pharmacy Forward View (CPFV) and engaging with local councillors.

Forward View resources We have produced an infographic flyer on the CPFV which describes how implementing the CPFV could help the NHS to cope with the pressures it is currently facing. It has been written for use as a discussion aid, to help guide conversations on the CPFV with external stakeholders.

PSNC’s Communications Team has also created a PowerPoint for patient groups following a suggestion from Hertfordshire LPC and similar work by Solihull LPC. The presentation gives a good overview of the current situation for community pharmacy and there are sections where LPCs can add relevant local information.

You can find these resources, plus much more, at: psnc.org.uk/campaign

Engaging with local councillors As part of PSNC’s 2017 Workplan, we are keen to engage with local councillors and have been discussing this with the other pharmacy organisations.

information that may be relevant to their role. The hub is now live at: psnc.org.uk/councillors - please direct any supportive local councillors to this webpage.

To help with this work, we have launched a new email targeted at local councillors, as well as a hub on the website for local councillors to visit. The email newsletter brings together content about community pharmacy services and our public affairs work to keep councillors updated with key

On 9th March PSNC, working with Pharmacy Voice and the NPA, exhibited at the Local Government Association (LGA) annual public health conference where we spoke to local councillors about community pharmacy and encouraged them to sign up to receive our emails.

Judicial Review of imposed funding cuts As you may already be aware, PSNC is seeking a Judicial Review of the imposed community pharmacy funding cuts, specifically the process that led to the decision. Below is a summary of the details relating to the Judicial Review.

Background PSNC issued proceedings in December 2016 and, after various submissions by both parties, the Honourable Mr Justice Ouseley granted leave or permission, for a Judicial Review, indicating that the hearing should be in February 2017.

In January, the Secretary of State succeeded in delaying the hearing until March 2017, so the PSNC case could be heard with the separate case brought by

4 Community Pharmacy News – March 2017

the NPA focusing on different grounds. The hearing will start at 2pm on Tuesday 21st March and will last approximately 3 days.

PSNC’s case PSNC believes that the Secretary of State made a major policy decision to restructure community pharmacy and make financial savings, without any proper evidence and without any meaningful consultation, to the detriment of the public who rely on the services of community pharmacies.

Outcome The Judicial Reviews requested by PSNC and the NPA took place as CPN went to print, so unfortunately we cannot bring you any outcomes from that here, but please check the PSNC website for any updates.

dispensing and supply

services and commissioning

The healThcare landscape

lpcs

Making sense of the Falsified Medicines Directive In preparation for the European Falsified Medicines Directive, new resources are now available for those working in community pharmacy in the UK. A new resource hub FMD Source (www.fmdsource.co.uk) has been launched to provide UK community pharmacists and their teams with detailed information to help them prepare for the start of the EU Falsified Medicines Directive (FMD).

FMD Source has been developed by the UK FMD Working Group for Community Pharmacy which brings together all the main bodies representing community pharmacy to influence and inform the implementation of FMD in the UK. It is designed to help UK pharmacies prepare for whatever new authentication systems are developed and introduced.

Under the EU Directive, all new packs of prescription medicines placed on the market in Europe from February 2019 onwards will have to bear two safety features: a unique identifier (UI) in the form of a 2D data matrix (barcode) and an anti-tamper device (ATD).

The UK’s database will be developed by a new organisation, SecurMed UK, which comprises of all the main supply chain

to the database, as well as for software upgrades.

The pharmacy negotiating bodies are represented on the UK FMD Working Group and are working hard to ensure there is a pragmatic solution that recognises the additional costs and impacts that FMD could have on community pharmacies and their suppliers.

bodies representing manufacturers, wholesalers and pharmacies. Pharmacy is represented jointly by the NPA and CCA and Raj Patel of the NPA is currently the “dispensing entities” Director of SecurMed UK. Who will be paying for FMD? The costs of establishing each database is to be borne by manufacturers of branded and generic medicines and parallel distributors though additional licensing fees. Pharmacies and wholesalers will be responsible for making their connections

Updated NHS Identity Guidelines: NHS logo use by pharmacies NHS England has updated its guidelines on the use of the NHS Identity, including revised guidance for all primary care contractors who are commissioned under a primary care contract such as community pharmacy contractors. The updated guidelines include information on the use of the NHS logo, which is a registered trademark protected by copyright.

Contractors who choose to use the NHS Identity must ensure that the revised guidance is adhered to and the new guidance includes a range of best practice examples demonstrating the correct use of the NHS Identity on various materials and in digital applications.

NHS England has advised that implementation of the updated NHS Identity guidelines should be gradual; existing offline materials should continue to be used until they need to be replenished or replaced. Contractors are, however, advised that they should aim to update existing digital channels, such as websites and social media accounts by January 2018.

A PSNC Briefing has been published summarising the main changes to the NHS Identity guidelines; read and download it from: ow.ly/hQIg308Xl6Y

What about Brexit?

Although the result of the referendum in 2016 has started the UK on a path towards leaving the European Union, it is unlikely that this will have taken place before FMD scanning and authentication comes in to effect from 9th February 2019. Other EEA countries and Switzerland are also participating in FMD. The full implementation of FMD may depend on the UK’s future relationship with the EU. Pack serialisation is now a global approach to tackling falsification and similar systems are being developed in many markets, including India and China. As a result, serialised packs are already appearing in UK pharmacies.

Annual NHS complaints report now due Community pharmacy contractors are reminded of the need to prepare their annual NHS complaints report for 2016/17.

The annual complaints report covers a number of aspects and must be available to any person on request. Information and guidance on how to compile the report can be found on the NHS Complaints Procedure part of the PSNC website: psnc.org.uk/NHScomplaints A copy of the completed report should be sent to the pharmacy’s local NHS England team as soon as practicable after 31st March 2017. Even if a pharmacy has not received any complaints, the contractor must prepare a complaints report confirming that they have received no complaints as part of their terms of service.

psnc.org.uk 5

services and commissioning

The healThcare landscape

lpcs

Prescribing: maintaining competence and confidence A comprehensive guide for pharmacist prescribers is published by the Centre for Pharmacy Postgraduate Education (CPPE).

We are pleased to announce the launch of an excellent new resource for prescribers – Prescribing: maintaining competence and confidence.

“

Dianne Bell

This guide has been developed to support pharmacist prescribers to identify their learning needs and signposts them to resources to help meet these needs.

Part 2 contains an extensive range of resources focused around the prescribing competencies, while Part 3 contains resources relevant to practitioners in more specialist roles where nonmedical prescribing is common. Each resource is clearly marked to determine whether it is free to all users, free to General Pharmaceutical Council registrants, free with registration or if a payment is required.

Linked to the Royal Pharmaceutical Society’s A competency framework for all prescribers, it will help learners to address most of the competency outcomes.

This resource also guides you to reflect on, plan, put into action and evaluate your learning, linking in with the cycle of your continuing professional development. This highly interactive PDF is now available on the CPPE website (www.cppe.ac.uk/programmes/l/prescribe-g-02), and hard copies will be delivered to every pharmacist registered with CPPE as a prescriber this month.

The guide is divided into three parts: Part 1 explains how to use a competency framework as a learning needs assessment tool and how to create a learning plan.

We trust that this guide will help you to update knowledge, develop skills and gather evidence of your competence to prescribe.

“

senior pharmacist, learning development, CPPE

Tackling high blood pressure

New resources from BLF

Pharmacy Voice, with the support of Public Health England, has published Tackling high blood pressure through community pharmacy, which focuses on the contributions of community pharmacy teams in the prevention, detection and management of high blood pressure.

The British Lung Foundation (BLF) has created two new resources aimed at pharmacists and their teams.

The report provides examples of campaigns, locally commissioned services and workplace-based initiatives that other pharmacy teams, commissioners and primary care colleagues could take inspiration from. Read the report in full at: ow.ly/BRmF309rcN6

Healthcare news in brief

The first is a simple guide to support pharmacists when talking to patients with a respiratory condition, focusing on the patient’s understanding of their medicines. The second is an introductory document explaining the role of the BLF and how the organisation can help pharmacy teams. Both of these new resources can be downloaded from: ow.ly/Zw2Q309fcnl As well as the new resources, the BLF website (www.blf.org.uk) has easyto-understand information and advice, a range of books and leaflets, and a web community that pharmacy teams can signpost patients to.

Here’s a round-up of what is going on in the wider health and care landscape beyond community pharmacy. For more information, please see the monthly updates at: psnc.org.uk/hclbriefings

Patient surveys suggest as many as 8 million more people would have gone to A&E over the last three years without NHS 111.

The King’s Fund has called on the Government to provide additional resources to support Sustainability and Transformation Plans (STPs).

A&E performance dropped to 86.74% of patients seen within four hours, compared to 90.65% in the same quarter last year.

6 Community Pharmacy News – March 2017

Age UK has reported that there are now over two million carers aged 65 and over.

The Health Foundation found there to be fewer hospital admissions for patients who experience a higher continuity of care from their GP practice.

psnc’s work

funding and sTaTisTics

conTracT and iT

dispensing and supply

Ask PSNC The PSNC Dispensing and Supply Team can provide pharmacy teams with support and advice on a range of topics related to the Drug Tariff and reimbursement. Questions asked in recent months have included: Q. I normally source my specials through a wholesaler – how will I be paid for (and how should I endorse) my specials?

A. Wholesalers typically categorise products as being either a ‘standard line’ or ‘special obtain’ item. Items classified as ‘special obtains’ are those which the wholesaler may not have readily available in stock and must ‘obtain specially’ on a bespoke ad-hoc basis. Items which are obtained in this way are not automatically considered as a ‘special unlicensed medicine’, e.g. food products, stoma or incontinence appliances, or vitamin supplement products.

To identify an unlicensed special, pharmacy staff should look for the wholesaler’s MHRA specials licence number on the product packaging and invoice. For unlicensed imports, the invoice will state the wholesaler’s MHRA importers licence number.

Where the unlicensed special is listed in Part VIIIB, the contractor will be paid this price regardless of how the product was sourced.

For those unlicensed specials and imports not listed in Part VIIIB, the contractor will be paid according to how the product was manufactured. Where the product is manufactured under an MHRA specials licence, community pharmacy contractors need to endorse: • Amount dispensed over pack size used; • Invoice price per pack size from which the order was supplied less any discount or rebate; • Manufacturers’/importers’ MHRA licence number; • Batch number of the product supplied; and • SP. Where the product is manufactured under the section 10 exemption of the Medicines Act 1968 (when a product can be made on a pharmacy premises without the need for a licence), contractors need to endorse the names, quantities and cost of the ingredients used in preparing the product.

Along with payment for the product, the contractor will also be paid the appropriate additional payment depending on whether the product was manufactured by a MHRA licensed specials manufacturer under their licence (they must endorse SP) or manufactured under the section 10 exemption by the contractor or by a 3rd party (they must endorse ED).

Q. I have received a prescription for Clotrimazole 10% cream 10g and Clotrimazole 2% cream 40g. How many prescription charges should the patient pay?

A. The patient would pay one prescription charge. This is because they are different strengths of the same formulation of drug.

For more information on prescription charges, see our ‘What does the patient pay?’ page (psnc.org.uk/patient-charges)

Q. I have received an electronic prescription for a contraceptive. The prescription was incorrectly marked as ‘paid’ when the reimbursement claim was sent. Will a charge be deducted during prescription pricing?

A. The following are automatically exempt from the prescription charge: • Prescriptions for contraceptives listed in the ‘List of Contraceptive Drugs to be Dispensed Free of Charge ’ in Part XVI of the Drug Tariff; • Prescriptions for contraceptive devices listed in Part IXA of the Drug Tariff; and • Spermicidal gels, creams, films and aerosols.

As with paper prescriptions, even if the claim is marked as ‘paid’, no charge will be deducted for these items.

Electronic prescriptions for other contraceptive drugs e.g.

Dianette will also be exempt from the prescription charge if the prescriber has made the endorsement ‘CC’ in the prescriber endorsement field in the electronic message.

Even if the prescription has been marked as ‘paid’ by the pharmacy, no charge will be deducted if the ‘CC’ endorsement has been made in the prescriber endorsement field.

Please note there is no exception from the requirement to obtain a completed exemption declaration on the grounds that the patient has been prescribed a contraceptive.

Look out for more frequently asked questions next month…

If you would like more information on any of the topics covered, the PSNC Dispensing and Supply Team will be happy to help (0203 1220 810 or e-mail info@psnc.org.uk). psnc.org.uk 7

dispensing and supply

services and commissioning

The healThcare landscape

Dispensing and Supply news Our Dispensing and Supply Team highlights the latest news, information and guidance that community pharmacy teams should be aware of.

Appliance update: Accu-Chek mobile cassettes Following some recent queries regarding mobile cassettes, the PSNC Dispensing and Supply Team want to make community pharmacy contractors and their teams aware that the Accu-Chek mobile cassette product is allowed on NHS prescriptions.

However, as of 1st February 2017, the packs of 100 cassettes have been discontinued. Therefore, only the packs of 50 will now be reimbursed by the Pricing Authority. If the pharmacy is presented with a prescription that states a pack size of 100 cassettes, they can dispense 2 packs of 50 cassettes and will be reimbursed as per their endorsement.

Removal from Part VIIIB of the Drug Tariff Glycopyrronium bromide 2mg/5ml oral solution and oral suspension has been removed from Part VIIIB of the Drug Tariff.

This is because a licenced alternative, Glycopyrronium bromide 400mcg/1ml oral solution sugar free, is now available and has been added to Part VIIIA effective from 1st March 2017.

Changes to the Drug Tariff impact on reimbursement so it’s important to take note when amendments are made to product listings.

Experiencing supply issues?

Pharmacy teams who experience problems in obtaining medicines or appliances are reminded to feed this back to our Dispensing and Supply Team.

PSNC reports the feedback received to the Department of Health to support their monitoring of the situation. It is also used in discussions with manufacturers, for example, highlighting problems with contingency arrangements.

Please report using our online feedback forms: psnc.org.uk/feedback

Can it be dispensed on an FP10?

When pharmacy teams receive NHS prescriptions, they must check whether the items prescribed are allowed on the NHS before dispensing otherwise the pharmacy contractor may not be paid for them. Below is a list of some products that we have recently received queries about.

Product

Is the item listed in the Drug Tariff?

Is it Does it in the have a ‘CE’ blacklist?* mark?

Can it be dispensed on an FP10?

Additional information

Piriton Allergy tablets

Yes

Yes

No

No

This item is not a medical device (CE marked) and appears in Part XVIIIA (the ‘blacklist’) of the Drug Tariff.

Verorab powder and solvent (Rabies vaccine)

No

No

No

Yes

This item is a not medical device (CE marked) and is not listed in Part XVIIIA (the ‘blacklist’) of the Drug Tariff.

Neilmed Sinus Rinse Kit

No

n/a

Yes

No

This item is a medical device (CE marked) and is not listed in Part IX of the Drug Tariff.

Proshield Foam and Spray skin cleanser

Yes

n/a

Yes

Yes

This item is a medical device and appears in Part IX of the Drug Tariff.

*n/a is because medical devices are not listed in the blacklist.

Please note: If the prescription is and FP10CN or FP10PN (community nurse prescriber), an FP10D (dental prescriber) or an FP10MDA (instalment dispensing), please visit psnc.org.uk/prescriptionforms for more information.

All details correct at time of printing.

No part of this publication may be reproduced without the written permission of PSNC. Produced for PSNC by Communications International Group.

Colour repro and printing by Truprint Media, Margate.

The publishers accept no responsibility for any statement made in signed contributions or in those reproduced from any other source.

8 Community Pharmacy News – March 2017

Distributed for PSNC by:

Communications International Group Linen Hall, 162-168 Regent Street, London W1B 5TB Tel: 020 7434 1530 Fax: 020 7437 0915

psnc’s work

funding and sTaTisTics

conTracT and iT

dispensing and supply

Pharmacy notice board In this section of Community Pharmacy News we have highlighted some key notices for you and your team to be aware of in the coming weeks and months.

Reminder: CPN to become online only

the last issue to This edition of PSNC's Community Pharmacy News (CPN) magazine will be Magazine.

Pharmacy with out mailed and be printed PSNC will continue to produce the online version of the CPN magazine, so that community pharmacists and their teams have a monthly guide to the most important pharmacy news from recent weeks. The online reader a downloadable can be used to browse on a computer, laptop, tablet or smartphone, whilst of publication The copy. paper a value PDF version will be made available for those who s. newsletter email these will be highlighted via our

Prescription Charge Card 2017

Each year PSNC provides a Prescription Charge Card for community pharmacies in England which is designed to be used as a poster.

At the time Community Pharmacy News (CPN) went to press the Department of Health had not confirmed what the charge would be from April 2017; we hope to have this finalised in time to include the poster with CPN, but look out for updates at: psnc.org.uk

Don’t forget to submit your flu

vaccination claims!

The national community pharmacy Flu Vaccination Service 2016/17 finishes at the end of this month (31st March 2017); community pharmacy contractors are therefore reminded of the need to submit payment claims for those vaccinations administered during March with their prescription bundle at the beginning of April.

The service specification for the community pharmacy Flu Vaccination Service states: “Payment claims for those vaccinations administered during March must be submitted to the NHS BSA by the 5th of April in line with the FP34C process. Late claims will not be processed.”

Failure to comply will result in contractors not being paid for flu

Making sure you will still receive important PSNC communications

Our website and email newsletters continue to be our primary methods of communication with community pharmacy contractors and their teams. It is therefore vital that you ensure you know how to access these channels and sign up for alerts where necessary – we suggest that you: 1. Bookmark our website: psnc.org.uk 2. Sign up for our emails: psnc.org.uk/enews 3. Follow us on social media: twitter.com/PSNCNews, www.facebook.com/psncnews and www.linkedin.com/company/pharmaceutical-services-negotiating-committee

psnc.org.uk 9

dispensing and supply

services and commissioning

The healThcare landscape

Drug Tariff Watch Below are the changes due to take place from 1st April 2017.

Part VIIIA additions Category A: • Phenobarbital 30mg/1ml solution for injection ampoules (10) • Phenobarbital 200mg/1ml solution for injection ampoules (10) • Pyrazinamide 500mg tablets (30) Category C: • Dipyridamole 200mg modified-release / Aspirin 25mg capsules SC (100) – Molita • Estradiol 75micrograms/24hours transdermal patches (8) – Evorel 75 • Flupentixol 100mg/1ml solution for injection ampoules (10) – Depixol Conc • Indacaterol 85micrograms/dose / Glycopyrronium bromide 54micrograms/dose inhalation powder capsules with device SC (10) – Ultibro Breezhaler • Indacaterol 85micrograms/dose / Glycopyrronium bromide 54micrograms/dose inhalation powder capsules with device SC (30) – Ultibro Breezhaler • Magnesium hydroxide 8% oral suspension (200ml) – J M Loveridge Ltd • Magnesium hydroxide 7.45-8.35% oral suspension BP (200ml) – Philips’ Milk of Magnesia • Mercaptopurine 20mg/ml oral suspension (100ml) – Xaluprine • Morphine sulfate 60mg/2ml solution for injection ampoules (5) – Wockhardt UK Ltd • Paracetamol 1g suppositories (10) – Typharm Ltd • Sodium citrate 4g oral powder sachets (6) – Numark cystitis treatment • Tiotropium bromide 10microgram inhalation powder capsules with

KEY: SC Special container R Item requiring reconstitution * This pack only (others already available)

device SC (30) – Braltus • Urea 5% / Lauromacrogols 3% cream SC (50g) – E45 Itch Relief • Urea 5% / Lauromacrogols 3% cream SC (100g) – E45 Itch Relief • Urea 5% / Lauromacrogols 3% cream SC (500g) – E45 Itch Relief • Ursodeoxycholic acid 250mg tablets (60) – Cholurso

Part VIIIA amendments • Venlafaxine 75mg modified-release capsules (28) Category C – Efexor XL is changing to Category C – Vensir XL • Venlafaxine 150mg modified-release capsules (28) Category C – Efexor XL is changing to Category C – Vensir XL Part VIIIA deletions • Conjugated oestrogens 1.25mg tablets and Norgestrel 150microgram tablets (120) Category C – Prempak-C • Conjugated oestrogens 625microgram tablets and Norgestrel 150microgram tablets (120) Category C – Prempak-C • Dipyridamole 200mg modified-release / Aspirin 25mg capsules (60) Category C – Asasantin Retard • Hexetidine 0.1% mouthwash sugar free (200ml) Category C – Oraldene • Isradipine 2.5mg tablets (56) Category A • Magnesium hydroxide 415mg/5ml oral suspension sugar free (200ml) Category C – Phillips' Milk of Magnesia • Magnesium hydroxide oral suspension 200ml Category C – J M Loveridge Ltd

Part IX deletions Take careful note of removals from Part IX because if you dispense a deleted product, prescriptions will be returned as disallowed.

Product

Size, type and product code

Silicone Elastomer (Male) – Universal Hospital Supplies Ltd 10ml balloon, 12-26 Ch (UN51161210-UN51162610) All Silicone (Male) – Universal Hospital Supplies Ltd

10ml balloon, 12-20 Ch (UN41151205-UN41152005)

Lubricious (Male) – Universal Hospital Supplies Ltd

10ml balloon, 12-26 Ch (UN51181210-UN51182610)

Sorbsan Plus Carbon

7.5cm x 10cm 10cm x 15cm 10cm x 20cm 15cm x 20cm 11cm x 11cm 15cm x 15cm 7cm x 9cm 15cm x 20cm 5cm x 5cm 10cm x 10cm 15cm x 15cm 350ml short tube (UN222V) 500ml short tube (UN333V) 500ml long tube (UN333VL) 750ml short tube (UN444V) 750ml long tube (UN444VL)

Trufoam Border – Square Trufoam Border – Rectangular Trufoam Non Adhesive – Square

Unicorn leg bag – Universal Hospital Supplies Ltd

Drug Tariff News: Medi Derma-Pro The Department of Health retrospectively added the following appliances to Part IXC of the Drug Tariff as of 1st March 2017: • Medi Derma-Pro Foam & Spray Incontinence Cleanser • Medi Derma-Pro Skin Protectant Ointment Prescriptions dispensed in March 2017 with these products on will be reimbursed by the Pricing Authority.

PSNC website For up to date information and news on community pharmacy issues, visit the PSNC website at psnc.org.uk PSNC Community Pharmacy News is published by: The Pharmaceutical Services Negotiating Committee, 14 Hosier Lane, London, EC1A 9LQ Community Pharmacy News is edited by: Melinda Mabbutt who can be contacted at the above address or by email at: mmabbutt@psnc.org.uk PSNC Office: 0203 122 0810

© PSNC